Neurocrine Biosciences Announces U.S. FDA Approval of INGREZ

SAN DIEGO, April 30, 2024 /PRNewswire/ -- Neurocrine Biosciences, Inc.  today announced the U.S. Food and Drug Administration has approved INGREZZA® SPRINKLE capsules, a new oral granules...

Related Keywords

San Diego , California , United States , Neurocrine Biosciences , Neurocrine Bioscience , Eiryw Roberts , Drug Administration , Prnewswire Neurocrine Biosciences Inc , Facebook , Twitter , Neurocrine Biosciences Inc , Nasdaq , Exchange Commission , Linkedin , Chief Medical Officer , Tardive Dyskinesia , Chorea Associated , Malignant Syndrome , Prescribing Information , Boxed Warning , Tardive Dyskinesia Patient , Disease Patient , All Rights , Markets ,